Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Immune Pharmaceuticals Company Profile (NASDAQ:IMNP)

Consensus Ratings for Immune Pharmaceuticals (NASDAQ:IMNP) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.00 (163.85% upside)

Analysts' Ratings History for Immune Pharmaceuticals (NASDAQ:IMNP)
Show:
DateFirmActionRatingPrice TargetDetailsShare
5/14/2014Chardan CapitalInitiated CoverageBuy$11.00ViewTweet This Rating  Share This Rating on StockTwits
3/10/2014ZacksReiterated RatingOutperform -> Outperform$9.00ViewTweet This Rating  Share This Rating on StockTwits
1/28/2014MLV & Co Initiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2012 forward)